Predictive Biomarkers for Allograft Rejection

Solutions Accelerated by IsoPlexis

  • Allograft Rejection Prediction

Apply PSI to inflammation in chronic allograft rejection

Uncover the biomarkers of inflammation that correspond with allogeneic T cell mediated injury

For additional cases in inflammation, download our EBook:

Download EBook

Research Area

Development Stage

Predict

Goal

Identify mechanisms of inflammation in chronic allograft rejection

How our Award-Winning IsoLight Single-Cell System is Making a Difference

polyfunctional cell

Solution

Polyfunctional profiles reveal differences in CD4+ and CD8+ Tem cell clones

polyfunctional cell

Finding

Activated T cell clones showed enhanced polyfunctionality

follow our data

Follow Our Data

See the latest published data in Inflammatory & Autoimmune Disease

  • Identify enhanced polyfunctionality of alloreactive CD4+ and CD8+ effector memory T cells (Tem) that play an important role in chronic allograft rejection.
  • Identify the correlation of high polyfunctionality of Tem to alloreactivity induced by allogeneic human endothelial cells (ECs).
  • Demonstrate panel reactive antibody (PRA) -treated ECs can promote the formation of highly polyfunctional Tem that may accelerate chronic allograft rejection.
  • Reveal the impact of highly polyfunctional Tem on allograft rejection and their potential for patient monitoring before and after organ transplantation.

For additional cases in inflammation, download our EBook:

Download EBook

[Ref: Xie et al. Human endothelial cells activated by complement membrane attack complexes differentially affect allogeneic CD4 and CD8 responses. Presented at Human and Translational Immunology 2019]

Request a Seminar

Request a Seminar
Discover IsoLight